Polidori, D., Iijima, H., Goda, M., Maruyama, N., Inagaki, N., & Crawford, P. (2018). Intra- and Inter-Subject Variability for Increases in Serum Ketone Bodies in Patients With Type 2 Diabetes Treated With the Sodium Glucose Co-transporter 2 Inhibitor Canagliflozin. Diabetes, Obesity & Metabolism. https://doi.org/10.1111/dom.13224 (Original work published 2018)